Transient expression of OCT4 is sufficient to allow human keratinocytes to change their differentiation pathway

Gene Therapy

Volumn 18, Issue 3, 2011, Pages 294-303

  Racila, D ^a   Winter, M ^a   Said, M ^a   Tomanek Chalkley, A ^a   Wiechert, S ^a   Eckert, R L ^b   Bickenbach, J R ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

epidermal cells; keratinocyte; reprogramming; stem cells; tissue repair

Indexed keywords

COLLAGEN GEL; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN;

ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MESENCHYME CELL; MYOFIBROBLAST; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN METHYLATION; SOMATIC CELL; TISSUE GRAFT; TRANSIENT EXPRESSION;

BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; DNA METHYLATION; DNA PRIMERS; FLOW CYTOMETRY; HUMANS; KERATINOCYTES; OCTAMER TRANSCRIPTION FACTOR-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSFECTION;

EID: 79952488548     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2010.148     Document Type: Article

References (34)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676. (Pubitemid 44233629)
2. Zhao R, Daley GQ. From fibroblasts to iPS cells: induced pluripotency by defined factors. J Cell Biochem 2008; 105: 949-955.
3. Yamanaka S. Induction of pluripotent stem cells from mouse fibroblasts by four transcription factors. Cell Prolif 2008; 41(Suppl 1): 51-56. (Pubitemid 350295862)
4. Hanna J, Wernig M, Markoulaki S, Sun C-W, Meissner A, Cassady JP et al. Tr e a t m e n t o f sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007; 318: 1920-1923.
5. Park I-H, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451: 141-146.
6. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripo-tent stem cells. Nature 2007; 448: 313-317. (Pubitemid 47080336)
7. Amabile G, Meissner A. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med 2009; 15: 59-68.
8. Okita K, Hong H, Takahashi K, Yamanaka S. Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc 2010; 5: 418-428.
9. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotech 2008; 26: 1276-1284.
10. Liang L, Bickenbach JR. Somatic epidermal stem cells can produce multiple cell lineages during development. Stem Cells 2002; 20: 21-31. (Pubitemid 34118907)
11. Schnerch A, Cerdan C, Bhatia M. Distinguishing between mouse and human pluripo-tent stem cell regulation: the best laid plans of mice and men. Stem Cells 2010; 28: 419-430.
12. Deng J, Shoemaker R, Xie B, Gore A, LeProust EM, Antosiewicz-Bourget J et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol 2009; 27: 353-360.
13. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 834-835.
14. Grinnell KL, Yang B, Eckert RL, Bickenbach JR. De-differentiation of mouse inter-follicular keratinocytes by the embryonic transcription factor Oct-4. J Invest Dermatol 2007; 127: 372-380. (Pubitemid 46106916)
15. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009; 27: 275-280.
16. Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH. Calcium regulation of growth and differentiation in mouse epidermal cells in culture. Cell 1980; 19: 245-254. (Pubitemid 10154229)
17. Ross JJ, Hong Z, Willenbring B, Zeng L, Isenberg B, Lee EH et al. Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells. J Clin Invest 2006; 116: 3139-3149. (Pubitemid 44878628)
18. Lau HK. Regulation of proteolytic enzymes and inhibitors in two smooth muscle cell phenotypes. Cardiovasc Res 1999; 43: 1049-1059. (Pubitemid 29413203)
19. Scholer H, Ruppert S, Suzuki N, Chowdhury K, Gruss P. New type of POU domain in germ line-specific protein Oct-4. Nature 1990; 344: 435-439.
20. Scholer HR, Dressler GR, Balling R, Rohdewohld H, Gruss P. Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBO J 1990; 9: 2185-2195.
21. Ovitt C, Scholer H. The molecular biology of Oct-4 in the early mouse embryo. Mol Hum Reprod 1998; 4: 1021-1031. (Pubitemid 28508992)
22. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 2003; 17: 126-140. (Pubitemid 36062514)
23. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003; 13: 631-642. (Pubitemid 36694188)
24. Kuroda T, Tada M, Kubota H, Kimura H, Hatano SY, Suemori H et al. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 2005; 25: 2475-2485. (Pubitemid 40354640)
25. Rodda D, Chew J, Lim L, Loh Y, Wang B, Ng H et al. Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 2005; 280: 24731-24737. (Pubitemid 40934562)
26. Varas F, Stadtfeld M, de Andres-Aguayo L, Maherali N, di Tullio A, Pantano L et al. Fibroblast-derived induced pluripotent stem cells show no common retroviral vector insertions. Stem Cells 2009; 27: 300-306.
27. Sommer CA, Stadtfeld M, Murphy GJ, Hochedlinger K, Kotton DN, Mostoslavsky G. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 2009; 27: 543-549.
28. Yusa K, Rad R, Takeda J, Bradley A. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods 2009; 6: 363-369.
29. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008; 322: 945-949.
30. Wong CJ, Casper RF, Rogers IM. Epigenetic changes to human umbilical cord blood cells cultured with three proteins indicate partial reprogramming to a pluripotent state. Exp Cell Res 2010; 316: 927-939.
31. Halprin KM. Epidermal 'turnover time'-a re-examination. Br J Dermatol 1972; 86: 14-19.
32. Webb A, Kaur P. Epidermal stem cells. Front Biosci 2006; 11: 1031-1041. (Pubitemid 43253459)
33. Jiang Y, Henderson D, Blackstad M, Chen A, Miller R, Verfaillie C. Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proc Natl Acad Sci USA 2003; 100: 11854-11860. (Pubitemid 37205895)
34. Torrado M, Lopez E, Centeno A, Medrano C, Castro-Beiras A, Mikhailov AT. Myocardin mRNA is augmented in the failing myocardium: expression profiling in the porcine model and human dilated cardiomyopathy. J Mol Med 2003; 81: 566-577. (Pubitemid 37214995)